Last 12 months
Inside the activity.
2 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC |
Duhon Lamar L.President, FPD
|
Tax withholdingCommon Stock | 10,346 | $87.02 | $900,308.92 |
DisclosureSEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · nonDerivative · entry 2 Duhon Lamar L. · CIK 0001904002 · President, FPD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,916 Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:36 UTC |
Duhon Lamar L.President, FPD
|
GrantCommon Stock | 26,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · nonDerivative · entry 1 Duhon Lamar L. · CIK 0001904002 · President, FPD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,262 Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 38,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008632 · wk-form4_1771364251.xml · derivative · entry 4 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,976 Underlying: Common Stock · 38,022 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantPerformance Rights · Derivative | 57,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008632 · wk-form4_1771364251.xml · derivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,196 Underlying: Common Stock · 57,034 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
VOPNI SCOTT KChief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 2,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008633 · wk-form4_1771364257.xml · derivative · entry 2 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,230 Underlying: Common Stock · 2,941 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
VOPNI SCOTT KChief Accounting Officer
|
GrantPerformance Rights · Derivative | 1,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008633 · wk-form4_1771364257.xml · derivative · entry 1 VOPNI SCOTT K · CIK 0001271969 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,105 Underlying: Common Stock · 1,260 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Schwetz Amy BChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008631 · wk-form4_1771364245.xml · derivative · entry 4 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,431 Underlying: Common Stock · 14,892 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Schwetz Amy BChief Financial Officer
|
GrantPerformance Rights · Derivative | 14,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008631 · wk-form4_1771364245.xml · derivative · entry 3 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,103 Underlying: Common Stock · 14,892 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Hudson Susan ClaireChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008629 · wk-form4_1771364229.xml · derivative · entry 4 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,315 Underlying: Common Stock · 7,287 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Hudson Susan ClaireChief Legal Officer
|
GrantPerformance Rights · Derivative | 7,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008629 · wk-form4_1771364229.xml · derivative · entry 3 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,981 Underlying: Common Stock · 7,287 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
DeBiasio Alice MariePresident, FCD
|
GrantRestricted Stock Units · Derivative | 5,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008630 · wk-form4_1771364237.xml · derivative · entry 2 DeBiasio Alice Marie · CIK 0002091999 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,216 Underlying: Common Stock · 5,703 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
DeBiasio Alice MariePresident, FCD
|
GrantPerformance Rights · Derivative | 5,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008630 · wk-form4_1771364237.xml · derivative · entry 1 DeBiasio Alice Marie · CIK 0002091999 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,703 Underlying: Common Stock · 5,703 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 5,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008628 · wk-form4_1771364221.xml · derivative · entry 2 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,156 Underlying: Common Stock · 5,069 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:37 UTC |
Boukalik BrianChief Human Resources Officer
|
GrantPerformance Rights · Derivative | 5,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008628 · wk-form4_1771364221.xml · derivative · entry 1 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,055 Underlying: Common Stock · 5,069 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:36 UTC |
Duhon Lamar L.President, FPD
|
GrantRestricted Stock Units · Derivative | 9,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · derivative · entry 4 Duhon Lamar L. · CIK 0001904002 · President, FPD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,082 Underlying: Common Stock · 9,505 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each anniversary of March 1, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:36 UTC |
Duhon Lamar L.President, FPD
|
GrantPerformance Rights · Derivative | 9,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-008626 · wk-form4_1771364211.xml · derivative · entry 3 Duhon Lamar L. · CIK 0001904002 · President, FPD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,090 Underlying: Common Stock · 9,505 shares Expires not disclosed F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% and are based on two factors during a three-year performance cycle beginning on January 1, 2026 and ending on December 31, 2028 which are: 1) the issuer's return on invested capital ("ROIC") measured against the issuer's target ROIC for each calendar year during the performance period; and 2) the issuer's average annual earnings per share growth over each calendar year during the performance period. The performance rights are also subject to a 15% payout modifier (positive or negative) based on the issuer's relative total shareholder return ("TSR") in comparison to the TSR of companies that comprise the S&P 500 Industrial Index for the entire performance period, as of January 1, 2026. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:17 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 839 | $87.37 | $73,303.43 |
DisclosureSEC source: 0001628280-26-007692 · wk-form4_1770931022.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,041 Underlying: Common Stock · 839 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:16 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 69 | $87.37 | $6,028.53 |
DisclosureSEC source: 0001628280-26-007691 · wk-form4_1770931016.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,193 Underlying: Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:16 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 345 | $87.37 | $30,142.65 |
DisclosureSEC source: 0001628280-26-007690 · wk-form4_1770931010.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,233 Underlying: Common Stock · 345 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| February 02, 2026 Filed Feb 3, 2026 21:25 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 84 | $78.15 | $6,564.60 |
DisclosureSEC source: 0001628280-26-005036 · wk-form4_1770153927.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,714 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in a prescheduled transaction. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:23 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionStock Option · Derivative | 114,943 | $0.00 Strike: $48.63 | $0.00 |
DisclosureSEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · derivative · entry 5 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 114,943 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested on April 1, 2020. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:23 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 2,517 | $70.92 | $178,505.64 |
DisclosureSEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 4 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,630 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.92 to $70.95. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:23 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 95,223 | $70.39 | $6,702,746.97 |
DisclosureSEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 3 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,147 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $69.92 to $70.91. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:23 UTC |
Rowe Robert ScottDirector · President & CEO
|
SaleCommon Stock | 114,943 | $70.54 | $8,108,079.22 |
DisclosureSEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 2 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,370 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.27 to $70.91. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 02, 2025 Filed Dec 3, 2025 21:23 UTC |
Rowe Robert ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 114,943 | $48.63 | $5,589,678.09 |
DisclosureSEC source: 0001628280-25-055043 · wk-form4_1764796993.xml · nonDerivative · entry 1 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 1, 2025 22:15 UTC |
DELLY GAYLA JDirector
|
GiftCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054495 · wk-form4_1764627309.xml · nonDerivative · entry 1 DELLY GAYLA J · CIK 0001218358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,496 F1 · shares: On December 1, 2025, the reporting person made a charitable gift of 900 shares of Common Stock. No shares were sold. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:04 UTC |
DELLY GAYLA JDirector
|
GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-053975 · wk-form4_1764104648.xml · nonDerivative · entry 1 DELLY GAYLA J · CIK 0001218358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,396 F1 · shares: On November 24, 2025, the reporting person made a charitable gift of 600 shares of Common Stock. No shares were sold. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 21:49 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 530 | $69.27 | $36,713.10 |
DisclosureSEC source: 0001628280-25-052105 · wk-form4_1763070553.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,202 Underlying: Common Stock · 530 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 21:49 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 435 | $69.27 | $30,132.45 |
DisclosureSEC source: 0001628280-25-052104 · wk-form4_1763070545.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 435 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 21:49 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 435 | $69.27 | $30,132.45 |
DisclosureSEC source: 0001628280-25-052103 · wk-form4_1763070539.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,888 Underlying: Common Stock · 435 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 21:48 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 87 | $69.27 | $6,026.49 |
DisclosureSEC source: 0001628280-25-052102 · wk-form4_1763070533.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,124 Underlying: Common Stock · 87 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 02:38 UTC |
Duhon Lamar L.President, FPD
|
SaleCommon Stock | 1,609 | $69.51 | $111,841.59 |
DisclosureSEC source: 0001628280-25-051805 · wk-form4_1763001498.xml · nonDerivative · entry 1 Duhon Lamar L. · CIK 0001904002 · President, FPD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,116 Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 22:13 UTC |
Schwetz Amy BChief Financial Officer
|
SaleCommon Stock | 47,000 | $71.02 | $3,337,940.00 |
DisclosureSEC source: 0001628280-25-049691 · wk-form4_1762380814.xml · nonDerivative · entry 1 Schwetz Amy B · CIK 0001647437 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,628 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $71.00 to $71.06. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 22:12 UTC |
Hudson Susan ClaireChief Legal Officer
|
SaleCommon Stock | 10,667 | $70.01 | $746,796.67 |
DisclosureSEC source: 0001628280-25-049688 · wk-form4_1762380723.xml · nonDerivative · entry 1 Hudson Susan Claire · CIK 0001929781 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,589 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $70.00 to $70.08. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 21:36 UTC |
DeBiasio Alice MariePresident, FCD
|
GrantRestricted Stock Units · Derivative | 13,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-047200 · wk-form4_1761773762.xml · derivative · entry 1 DeBiasio Alice Marie · CIK 0002091999 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,513 Underlying: Common Stock · 13,513 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period on each annual anniversary of the grant. Read SEC document |
| October 01, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 18 | $53.14 | $956.52 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 11 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,332 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| September 02, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 26 | $53.66 | $1,395.16 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 10 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,314 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 20:24 UTC |
Wilson KirkPresident, FCD
|
SaleCommon Stock | 10,000 | $53.22 | $532,200.00 |
DisclosureSEC source: 0001654776-25-000004 · wk-form4_1755030262.xml · nonDerivative · entry 1 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,196 F1 · shares: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.20 to $53.26, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| August 08, 2025 Filed Aug 11, 2025 21:28 UTC |
Wilson KirkPresident, FCD
|
SaleCommon Stock | 10,000 | $52.58 | $525,800.00 |
DisclosureSEC source: 0001628280-25-039651 · wk-form4_1754947694.xml · nonDerivative · entry 1 Wilson Kirk · CIK 0001654776 · President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,196 F1 · shares: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.56 to $52.62, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| August 01, 2025 Filed Nov 3, 2025 23:06 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 10 | $56.04 | $560.40 |
DisclosureSEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 9 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,370 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| August 01, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 16 | $56.04 | $896.64 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 9 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,288 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:29 UTC |
Johnson Cheryl HDirector
|
GrantPhantom Stock · Derivative | 540 | $55.95 | $30,213.00 |
DisclosureSEC source: 0001628280-25-036737 · wk-form4_1753907385.xml · derivative · entry 1 Johnson Cheryl H · CIK 0001552649 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453 Underlying: Common Stock · 540 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:32 UTC |
CHANDY RUBY RDirector
|
GrantPhantom Stock · Derivative | 107 | $55.95 | $5,986.65 |
DisclosureSEC source: 0001628280-25-036741 · wk-form4_1753907547.xml · derivative · entry 1 CHANDY RUBY R · CIK 0001358419 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,037 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:28 UTC |
SIEGEL KENNETH IDirector
|
GrantPhantom Stock · Derivative | 540 | $55.95 | $30,213.00 |
DisclosureSEC source: 0001628280-25-036735 · wk-form4_1753907286.xml · derivative · entry 1 SIEGEL KENNETH I · CIK 0001465558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,065 Underlying: Common Stock · 540 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| July 30, 2025 Filed Jul 30, 2025 20:25 UTC |
GARRISON JOHN L JRDirector
|
GrantPhantom Stock · Derivative | 830 | $55.95 | $46,438.50 |
DisclosureSEC source: 0001628280-25-036732 · wk-form4_1753907149.xml · derivative · entry 1 GARRISON JOHN L JR · CIK 0001656422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,672 Underlying: Common Stock · 830 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock, and represents director compensation deferred in the form of common stock pursuant to the issuer's deferred compensation plan. F2 · derivative.exercise_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. F2 · derivative.expiration_date: The shares of phantom stock become payable in the form of common stock upon the reporting person's termination of service as a member of the issuer's board of directors. Read SEC document |
| July 01, 2025 Filed Nov 3, 2025 23:06 UTC |
Rowe Robert ScottDirector · President & CEO
|
GrantCommon Stock | 85 | $52.35 | $4,449.75 |
DisclosureSEC source: 0001628280-25-048418 · wk-form4_1762211188.xml · nonDerivative · entry 8 Rowe Robert Scott · CIK 0001608962 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,360 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| July 01, 2025 Filed Nov 3, 2025 22:59 UTC |
Wilson KirkFormer President, FCD
|
GrantCommon Stock | 18 | $52.35 | $942.30 |
DisclosureSEC source: 0001628280-25-048410 · wk-form4_1762210767.xml · nonDerivative · entry 8 Wilson Kirk · CIK 0001654776 · Former President, FCD 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,272 F1 · security: Shares acquired under the non-qualified Flowserve Corporation 2024 Employee Stock Purchase Plan in monthly, prescheduled transactions that were previously inadvertently not disclosed. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:12 UTC |
Boukalik BrianChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 682 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · derivative · entry 3 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,087 Underlying: Common Stock · 682 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive, at settlement, one share of common stock (plus dividends accrued on the underlying shares) and are granted to the reporting person pursuant to the issuer's long-term incentive compensation plan for employees. The shares vest ratably over a three-year period beginning on June 15, 2025. Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:12 UTC |
Boukalik BrianChief Human Resources Officer
|
Tax withholdingCommon Stock | 169 | $46.46 | $7,851.74 |
DisclosureSEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · nonDerivative · entry 2 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421 Read SEC document |
| June 15, 2025 Filed Jun 17, 2025 20:12 UTC |
Boukalik BrianChief Human Resources Officer
|
Exercise / conversionCommon Stock | 693 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-031842 · wk-form4_1750191121.xml · nonDerivative · entry 1 Boukalik Brian · CIK 0002024241 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,590 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.